US 11198699
Compounds targeting PRMT5
granted A61KA61K31/437A61K31/519
Quick answer
US patent 11198699 (Compounds targeting PRMT5) held by Aligos Therapeutics, Inc. expires Mon Dec 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aligos Therapeutics, Inc.
- Grant date
- Tue Dec 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K31/437, A61K31/519, A61K31/52, A61K31/522